Doctor Explains Why Weight Loss Drugs Like Ozempic Are Truly A Medical Breakthrough

“My body was completely stuck,” she said. While rare, serious side effects including pancreatitis have also been reported. Common side effects of Ozempic and Wegovy include stomach pain, nausea, vomiting, diarrhea and other gastric symptoms. In addition to causing heart problems, some earlier pills caused psychiatric side effects, such as depression, according to Buettner. It is primarily used to treat type 2 diabetes, but it has also been found to have a significant weight loss effect. In this article, we’ll explore what drug is like Ozempic for weight loss, discussing their similarities, differences, and benefits. The worry is that researchers might be influenced by their relationship with Novo Nordrisk to produce study results that are more favorable to the medications. In fact, BMI only accounts for ∼17% of the risk of insulin resistance and subsequent type 2 diabetes in BMI ≥ 25 kg/m2 population . A consideration is that recent literature has shown that the correlation between the body mass index and disease risk is not linear . Overall, these studies indicate that danuglipron is a promising antidiabetic drug that may increase adherence in patients given its form of delivery and ease of administration. This phase 2 study reported that HbA1c% levels were reduced by 1.16% points in the 120 mg (twice a day) group and they also experienced the highest weight loss (−2.04 kg) in the cohort . In another phase 1 study conducted on patients with type 2 diabetes, researchers implemented an ascending dosage order starting from 10 mg twice a day to 120 mg twice a day . However, “there are other injectable therapies available for weight management,” Dr. Jaisinghani explains. Trulicty (dulaglutide) is an oral GLP-1 medication, Dr. Adimoolam explains. “Patients who find subcutaneous (under the skin) administration inconvenient or unsuitable might benefit from an oral medication option,” Dr. Jaisinghani notes. “At least 25% of the patients I see don't want anything to do with needles,” she notes. The pill versions are especially good for “needle phobic” people, Levy says. The lowest doses cost $149 a month for people paying out of pocket, a cheaper alternative to the injectable Wegovy.

If you can think of others, feel free to share in the comments.

The efficacy of Ozempic and other weight-loss medications allows health care professionals to manage obesity much in the same way they manage other chronic diseases like high blood pressure and asthma. Food and Drug Administration (FDA) to treat type 2 diabetes, not obesity—make other drugs used for weight loss obsolete? Novo Nordisk’s diabetes medication Ozempic and weight-loss drug Wegovy are two brand names for an agonist called semaglutide, which binds to specific receptors in the body to trigger the release of the hormone glucagonlike peptide-1 (GLP-1). People who are good candidates for weight loss medications often have health risks that are greater than the low risk of thyroid cancer. Some research has found a small increased risk of kidney cancer for people taking GLP-1 weight loss drugs.

Does Ozempic (Semaglutide) Lower the Risk of Dementia?

Benefits of NAD Supplement: What NAD+ Does for Energy, Aging, Cognitive Function, and Cellular Health A healthcare provider can help set realistic goals and track progress during the treatment process. It’s important to manage expectations and understand that weight loss is gradual and sustained over time. These symptoms are usually mild to moderate and may decrease over time as the body adjusts to the medication. Like any medication, Ozempic can cause side effects, although not everyone will experience them. The objective is to provide effective weight management solutions for those who find it challenging to achieve weight loss through diet and exercise alone. The company said it has long covered GLP-1s for both weight loss and diabetes, but recently added new requirements, including documentation from a medical provider and enrollment in a virtual health program called Omada. North Carolina is one of just 13 states whose Medicaid program covers GLP-1s for weight loss, meaning the drugs are available to the state’s lowest-income residents. Originally developed for diabetes, GLP-1s soon became recognized for their ability to help patients lose 15 percent or more of their body weight through weekly injections. Patients not only lose weight but also often see improvements in blood pressure, cholesterol and blood sugar — factors that reduce their risk for heart disease and diabetes. If this sounds unsettling, it's a reminder of how high the stakes are to combat obesity. Generally, if you don't have a history of these conditions, "this medication is thought to be safe," he says. So, Kushner says doctors need to screen patients to find out if they have a family history of a specific kind of thyroid carcinoma, or another rare condition called multiple endocrine neoplasia syndrome type 2 (MEN 2). But the drug does carry a black box warning because in rodent studies it caused thyroid tumors. There's ongoing research to evaluate the drug's effect on the cardiovascular system, which is positive so far. “There’s a concern that maybe they’ll have some effect that we just don’t know in the long term,” Hari told TODAY.com, echoing a worry other patients may have. “We’re going to have more treatments that are even more effective,” Aronne said. But Hsueh also pointed out that “some patients prefer a once-a-week injection rather than a pill, especially if they already take a handful of pills daily.” Triple–hormone-receptor agonist retatrutide for obesity — A Phase 2 trial. Another drug in development could one-up even tirzepatide. Still, pharmaceutical companies are racing to investigate new, improved relatives of semaglutide. Yet semaglutide may have an even more dramatic action — saving lives, scientists suggested November 11 in Philadelphia at the American Heart Association meeting. Semaglutide mimics a gut hormone, GLP-1, that’s secreted after people eat. She had recently given birth, and her body had changed. The other day in my primary care practice, one of my patients asked me to prescribe Ozempic. KFF Health News, formerly known as Kaiser Health News (KHN), is a national newsroom that produces in-depth journalism about health issues and is part of KFF, an independent source for health policy research, polling, and journalism. It is also a controlled substance and carries with it the risk of addiction. Nevertheless, for obvious reasons, orlistat users are strongly advised to maintain low-fat diets while on the medication. Generally considered safe and well-tolerated, some side effects of metformin may include stomach upset, as well as mild nausea or diarrhea. For this reason, people with heart conditions and liver problems should absolutely consult a doctor or nutrition expert before trying MCT oil. Combining the two drugs increases efficacy. Interactions may occur during or within 14 days following the use of monoamine oxidase (MAO) inhibitors, sympathomimetics, alcohol, adrenergic neuron-blocking drugs, and possibly some anesthetic agents. Side effects include headache, overstimulation, high blood pressure, insomnia, rapid or irregular heart rate, and tremor. Tirzepatide was previously approved to treat type 2 diabetes as Mounjaro, and it goes by that name only in some countries. Like semaglutide, it works by reducing appetite and is meant to be used in combination with diet and exercise to lose weight. For Wharton, having these pills as treatment options is a matter of accessibility. “Thankfully, it looks very safe,” Drucker says, but scientists still need to do longer-term studies in larger groups of people. A pill like orforglipron requires no injector pen and no refrigeration and it’s relatively easy to manufacture, Drucker says — all of which should cut costs. Unlike the large synthetic molecule semaglutide, orforglipron is a small molecule, though both act by mimicking GLP-1. In one of the new clinical trials, Wharton and other researchers tested a higher-dose version of the drug, 25 milligrams rather than 14 milligrams, which is the highest dose Rybelsus comes in. Antidepressants vary widely in their physical side effects Additionally, we offer quick-access supplements like GLP-1 Daily Support and Weight Loss Boost, designed to complement your weight loss efforts without requiring an assessment quiz. If you’re interested in exploring personalized weight loss solutions, we invite you to take our free assessment quiz here. At TrimRx, we believe that every weight loss journey is unique. Regular exercise is crucial for maintaining a healthy weight. Doctors prescribe metformin to lower blood sugar levels in people with prediabetes. Ozempic can lower blood sugar and lead to significant weight loss. These medicines can lead to even more weight loss – about a 10% to 20% drop in body weight after a year. Wegovy won FDA approval to reduce the risk of heart attacks, strokes, or cardiovascular death, and Zepbound recently became the first drug approved for obstructive sleep apnea. Medications for weight loss have soared in popularity since 2017, when Ozempic was first approved by the Food and Drug Administration (FDA). He specializes in patients with diabetes and obesity. There are several ways to lose weight that doesn't involve the use of prescription medications. Plus, you're at risk of losing muscle mass if you stop strength training while on these medications. This drug combination was explicitly rejected multiple times for safety reasons in Europe, but remains for sale in the United States. Like smoking, popping these pills can cause you to lose weight, but at what cost? Judges concluded that the drug company’s priority was systematically given to “preserving its own economic interests over the safety of the drug’s consumers.” It has real potential to improve metabolic health, but only if it's used correctly and for the right reasons.” GLP-1 helps to stimulate insulin production, lower blood sugar levels, and suppress appetite. Below, discover everything you need to know about Ozempic so you don’t have to pretend to know what you’re talking about the next time it comes up in conversation—and maybe even determine if it’s right for you. Setting specific, achievable fitness goals can help promote consistency, making it easier to stick to an active lifestyle alongside medication use. For patients navigating weight management options, collaborating with healthcare professionals remains vital. This medication often suits short-term use; therefore, patients must carefully manage their experiences during treatment. Gastrointestinal side effects frequently emerge with medications in the GLP-1 receptor agonist class, including Ozempic. Individuals must pay attention to how these medications interact with their unique health profiles and lifestyles. If you have a Medicare health plan, consider other benefits that could help you with weight management, such as nutrition counseling. If you pay for a GLP-1 yourself, without using insurance, the proposed plans could mean you end up spending much less on your medications. The Trump administration announced in early November that it had struck a deal with leading GLP-1 pharmaceutical manufacturers, Eli Lilly and Novo Nordisk, to lower consumer prices for GLP-1 medications. Despite their rising popularity, the prices for these medications, which have a list price of $1,000 or more per month, have not decreased, and most adults who use them report that they are difficult to afford. A recent report from the health policy nonprofit KFF found that across age groups, GLP-1 use is highest among people between the ages of 50 and 64. Talk to your healthcare team about ways you can avoid gallbladder problems while taking semaglutide. It was reported in less than 2% of people using semaglutide in clinical trials. But it’s not clear yet if this is from semaglutide or another cause. Your healthcare team can help you ensure you’re getting adequate nutrition during treatment. Studies that recruit participants in China are also important for investigating the efficacy of GLP-1 drugs in Asian populations, which could reveal differences not observed in studies from Europe or the United States. “It’ll give us options and it will make personalized medicine in obesity and diabetes more accessible.” Other trials are testing whether the drug can treat sleep apnoea or type 2 diabetes. Dozens of GLP-1 drugs are being developed and tested in China, with “many more to come”, says Drucker. The study, funded by drug manufacturer Sciwind Biosciences, based in Hangzhou, China, included 664 people given either a weekly injection of a placebo, or one of three doses of ecnoglutide.

When Less is More: How Microdosing GLP-1s Can Personalize Your Weight Care Journey

Pharmacies can mix up versions of drugs in various instances in order to, you know, make it available, for instance, in times of shortage. Essentially, compounded drugs have long existed. And so they say, we have this long track record of using them in people with diabetes. The second, retatrutide, has an unprecedented level of efficacy, and could raise the bar for pharmacological obesity treatment. But an Eli Lilly spokesperson told Women's Health that the company plans to submit data for orforglipron as a weight-loss drug to regulatory agencies by the end of this year. Orforglipron isn’t an FDA-approved medication, and more research is needed before Eli Lilly even submits data on it for approval. The trial found that the safety profile of orforglipron was similar to what it is for other GLP-1 medications, like Ozempic. If the medication is approved by the FDA, it could be a game-changer for some, according to Mir Ali, MD, medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA. How well do these new GLP-1 agonist drugs really work? The current crop of approved meds includes Qsymia, a combination of phentermine, the phen in fen-phen, and topiramate, a drug that can cause seizures if you abruptly stop taking it. The goal of weight loss is not to fit into a skinnier casket. The drug company knew about the risks, but covered them up. Doctors are perhaps the most guilty of perpetuating the myth that weight loss solves everything. With budgets like that, it's no wonder my patients seem to think Ozempic is a miracle drug. Ozempic and Wegovy sales are estimated at $13 billion a year, a true windfall for Novo Nordisk, the Danish pharmaceutical company that developed the blockbuster drugs. Rather than fixing discrimination against people with bigger bodies, we tell patients to fix themselves.
Wegovy has heart health benefits even if weight loss is minimal
  • He did report the side effects to his doctor, who suggested that increasing his dosage more slowly might help.
  • Maintaining a nutritious diet and exercise routine can help minimize potential rebound weight gain.
  • “Phentermine can cause a lot of side effects, including hypertension, worsening cardiovascular disease and rapid heart rate,” Dr. Misra says.
  • Incidentally, Andy Cohen also shared in September that he lost "a good chunk of weight by micro-dosing a GLP-1."
  • Www.fda.gov/drugs/news-events-human-drugs/fda-approves-treatment-chronic-weight-management-pediatric-patients-aged-12-years-and-older
  • Hormone levels and other factors can affect vaginal health and appearance, as can certain medications.
  • Was it with the approval of Wegovy, which is basically the same ingredient as Ozempic for weight loss?
Other injectables that also help lower weight such as Ozempic, Mounjaro and Saxenda rapidly entered the market, along with various non–FDA approved products like Aqualyx, Lipodissolve and concoctions brewed up by specialty pharmacies and sketchy wellness clinics. The world has launched into an era of injectables not just to treat obesity but to manage weight. In the meantime, the study findings underscore the importance of getting these medicines from a doctor, and not from the internet, so that it’s possible to have a thorough discussion of the potential risks, Dr. Garvey says. The study wasn’t designed to prove whether or how GLP-1 drugs might directly cause gastrointestinal complications. The final analysis included 613 people prescribed semaglutide, 4,144 people prescribed liraglutide, and 654 people on the bupropion-naltrexone combination pill. Or take Benfluorex, like Ozempic, another diabetes drug repurposed as an appetite suppressant. It's possible that we can find better ways of supporting people once they come off AOMs – or find healthier alternatives to them. The team also found that people who lost more weight tended to regain more afterwards too. While GLP-1 drugs promote fat loss, rapid weight reduction can lead to 15–25% lean muscle mass loss. “The patients taking GLP-1 RA medications report that the ‘food noise’ — the constant thinking about food — is quieter,” Ali said. Research is still unraveling how GLP-1 drugs influence the body, from the gut and cardiovascular system to muscular and brain function. “Lowering prices might encourage more people who might benefit from these medications to start using them.” What are the benefits of using a drug like Ozempic for weight loss? Ozempic and Wegovy are in a class of medications known as GLP-1 receptor agonists. Using a medication “off-label” means it’s prescribed for a use other than its stated purpose. That’s because semaglutide, the generic name for Ozempic and Wegovy™, is highly effective in treating several chronic diseases, including having obesity.
  • Plenty of people who are considered overweight by current measures are metabolically healthy, and plenty of people who aren't considered overweight are not, as demonstrated by research in JAMA Internal Medicine.
  • “I found that my cholesterol went up to 200 when I gained the extra weight.
  • Yes, Ozempic can be used long-term for weight management, but this decision should be made in consultation with a healthcare provider.
  • After losing a significant amount of weight over several years through lifestyle changes, Kathy clarified last October that she’d lost an additional 20 lbs due to Ozempic.
  • Nevertheless, some patients experience enduring symptoms, which may deter them from continuing treatment.
  • “In the next five years, we’ll know so much more and be able to treat patients with greater safety and efficacy for diseases that have been lost causes for decades,” Abraham concludes.
  • But, you know, some people just take these drugs and they feel so ill that they just can't stay on them, right?
  • You’ve no doubt heard “Ozempic” being used as a catch-all term for weight loss medication in the last few years.
Your health care professional may prescribe a medication to treat your overweight or obesity if you are an adult with Prescription medications to treat overweight and obesity work in different ways. You can calculate your BMI to learn if you are overweight, have obesity, or have severe obesity, which may increase your risk of health problems. GLP-1 (glucagon-like peptide-1) medications are as popular as ever for weight loss. Along with helping to control blood sugar and boosting weight loss, GLP-1 agonists and SGLT-2 inhibitors seem to have other health benefits. In my view, they warrant much more research before they become the basis for a new weight management protocol. Then I show that, aside from surgical intervention, the best way to lower body fat is by starting an exercise program and improving dietary habits. Globally, more than 650 million people are obese, and by 2030, an estimated 1 billion adults will be obese. The field of weight management is evolving–and fast. “Once-Weekly Semaglutide in Adults with Overweight or Obesity.” In the 2025 RAND survey, about half of patients taking a GLP-1 drug said they experienced nausea and one-third experienced diarrhea. Semaglutide is a synthetic version of a hormone known as GLP-1, which the body releases into the intestine when people eat food, as TODAY.com previously reported. It’s not unusual for doctors to prescribe Ozempic off-label for weight loss, Hurtado Andrade says. Semaglutide in pill form is in the works and may be appealing to more people when it's approved. Other people are microdosing semaglutide — taking much smaller doses than recommended — to save money and for other reasons, though many doctors warn against the practice. For instance, those who took GLP-1RAs had a 9%, 8% and 12% reduced risk of having a heart attack, deep vein thrombosis and Alzheimer's, respectively, compared to controls. Overall, the researchers found that GLP-1RAs have many beneficial effects, some of which were previously recognized. However, concerns have also been raised regarding the negative side effects of taking GLP-1RAs, including reports of gastrointestinal issues. One study revealed that psyllium husk resulted in reduced body weight, blood sugar levels, constipation, and cholesterol. Has been FDA-approved for weight loss,” is an Ozempic alternative for those looking to lose weight, Dr. Adimoolam says. Despite its popularity for those looking to lose weight, Ozempic is actually not approved by the FDA for weight loss. Many patients on the medication reach an A1C of under 7%, a goal for many adults with diabetes, according to the American Diabetes Association (ADA). That myth is nothing new, but it's been newly medicalized in the era of Ozempic and Wegovy, a class of medications known as GLP-1 agonists. Was that a reason to start a weight-loss medication? "People are not going to be able to plunk down a grand every month. A lot of people will go off the drug, and that's a shame." It's possible that the rapid correction of high blood sugar induced by GLP-1 drugs rather than a toxic effect "could be a possible mechanism for vision loss," the 2025 study noted. A previous study suggested people taking semaglutide may be at increased risk for this condition, described as "a stroke of the optic nerve." But people who notice any new changes in their vision while taking these medications should promptly inform their doctor or see an eye care specialist, they urge. Evidence is additionally emerging to suggest that GLP-1RAs may help prevent the onset of conditions such as Alzheimer's disease and help patients to manage others like substance-use disorders. RAND is a research organization that develops solutions to public policy challenges to help make communities throughout the world safer and more secure, healthier and more prosperous. The data are weighted to represent the English-speaking adult population in the United States by age, sex, race, ethnicity, income, education level, and household size. The majority of those who reported having side effects noted that they are mild and not serious.
  • A landmark placebo‑controlled trial reported mean losses approaching the mid‑teens (% body weight) at 68 weeks on 2.4 mg weekly, illustrating the upper end of what the class can achieve when maximally dosed and supported (note that this differs from Ozempic’s lower diabetes doses).
  • Not only do drugs like Ozempic make you feel more satiated, but their effect on insulin can assist with weight loss as well.
  • Scott Butsch, MD, explains why Ozempic has become so popular for weight management.
  • GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications that work by mimicking the natural GLP-1 hormone.
  • One role of GLP-1 is to prompt the body to produce more insulin, which reduces blood sugar (glucose).
  • Some off-label prescribing even has accumulated a growing body of high-quality evidence.
By raising hormone levels, semaglutide and similar GLP-1 agonists restore the correct hormone balance, although their effect seems to end if people stop taking the drugs. GLP-1 levels can be disrupted in people who are overweight or have diabetes, which causes the body to consume more than it needs instead of recognizing that it is full. So Leggio and other addiction researchers are starting their own studies to directly test whether these drugs, and newer generations of them, will be as safe and effective for treating drug and alcohol addiction as they are for facilitating weight loss. The abundance of anecdotal reports has made researchers wonder whether Ozempic and similar weight-loss drugs can serve as a basis for antiaddiction treatments. Some users of Ozempic, the popular diabetes drug that can help people eat less and lose weight, have been noticing a welcome side effect.
Lithium study yields insights in the fight against HIV
PCOS often causes insulin resistance (when your body doesn’t respond properly to this hormone) and weight gain. Although metformin and Ozempic aren't prescribed for weight loss, both medicines can cause you to lose weight. People with overweight or obesity may benefit more from Ozempic.
  • All GLP-1 agonists can help with weight loss.
  • Mounjaro, the brand name for tirzepatide, was approved for diabetes last year and is “being fast-tracked through the FDA currently for approval for obesity,” says Dr. Stanford.
  • The off-label designation means that prescription insurance generally won’t cover Ozempic for weight loss alone.
  • Moore shared highlights of what consumers should know, addressing some of the FDA concerns about fake products, lack of sterility, adverse events and dosing errors within the burgeoning compounded drug scene.
  • While we may not understand how these drugs affect people with FSHD, some research has been done on GLP-1 agonists and age-related muscle loss.
  • Ozempic is not technically approved for weight loss.
If you wonder about the ethics of direct-to-consumer TV ads that funnel viewers to particular drugs, then this Web marketing strategy should raise even greater fears. Let’s say, also conservatively, about a third of both obese and weight conscious people in the U.S. go on one of the injectables—that’s a hundred million of us. They may also be used to prevent weight gain by people who care deeply about their appearance, and those who won’t or can’t change their diets and lifestyles. What is now approved for adults will soon be being used by other groups, with or without regulatory approval—by children, the worried well, those who need to maintain low weight for their jobs (in particular, members of the military). Then, on November 8, 2023 the FDA granted Lilly, which manufactures Mounjaro, approval to sell/market its new drug Zepbound for chronic weight management. “It’s willpower.”“I’m like, do people want me to be drinking again? Fans constantly point fingers at Jessica Simpson for apparently being too skinny and taking Ozempic.The pop singer denied using GLP-1 medication while addressing the claims during a 2023 interview with Bustle.“Oh, Lord. She is obees and it will be good for her to lose weight. Kelly Clarkson is probably a lot healthier now as well obviously slimmer. Looks more like eating tiny portions, or just looks in the mirror and sees herself as overweight? Food and Drug Administration (FDA) in 2017 for treating type 2 diabetes (TD2), Ozempic has seen one of the fastest adoption rates in U.S. pharmaceutical history, thanks in large part to its success in also promoting weight loss. But Patel emphasizes it’s not a quick fix—the medication is dosed upward slowly over several months—and for some people, it’s not a fix at all. “The body has mechanisms in place that are trying to fight that weight loss,” she says. “When weight isn’t regulated properly by the body, we have obesity.” For the scores of people seeing weight loss success on prescription injectables such as Ozempic, Wegovy, Saxenda, and others, the number on the scale isn’t the only change they’re experiencing. Lifestyle medicine practitioners partner with patients to understand their core values and help them achieve goals — whether it's to lose 20 pounds, control high blood pressure or boost mood and energy. Our society's easy access to ultraprocessed, calorie-dense foods and our high levels of inactivity contribute to excessive weight gain and related health impacts. More than half of employer insurance plans in the United States, as well as Medicare, don't cover the medicines for weight loss. The high price of the weight-loss medicines — usually over $1,000 per month for each patient — is especially troubling in a nation that already far outspends the rest of the world in health care costs and faces major disparities in care. For primary care doctors like me, who have counseled thousands of patients — often unsuccessfully — about their weight, this news is welcome. This can result in significant weight loss — for people with or without diabetes. You can view a filtered list of clinical studies on prescription medications to treat overweight and obesity that are federally funded, open, and recruiting at ClinicalTrials.gov. Researchers are studying many aspects of prescription medications to treat overweight or obesity, such a By choosing an off-label medication to treat overweight and obesity, your health care professional may prescribe Sometimes health care professionals use medications in a way that’s different from what the FDA has approved. This helps regulate appetite and blood sugar. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider. If the needle is left on, medication may leak from the pen. “I think as of now data are really limited regarding the GLP-1 agonists and effects on muscle wasting in muscular dystrophy or FSHD,” wrote Jeffrey Statland, MD, in a recent email. For a typical overweight or obese person who loses weight by dieting, about 20% to 30% of the loss may be lean tissue, according to a May 2017 article in Advances in Nutrition. They work like a hormone in your body named GLP-1 (glucagon-like peptide 1), one of a group of gut peptides called incretins that are secreted when you eat. The celebrity chef looks unrecognizable after losing a significant amount of weight over the years, and one of Deen's major physical changes has been her face. “For that reason, I think it’s so important for us not to judge others for the choices they make while on this journey. Charlot predicts the impact on the health and wellness industry as a whole will be neutral. “We want to make sure people are aware of all the options available,” Simonetti said.
The bones: Hidden risks
You probably will regain some weight after you stop taking weight management medication. Most side effects are mild and most often improve if you continue to take the medication. For this reason, never take a weight management medication only to improve the way you look. Medications don’t replace physical activity or healthy eating habits as a way to lose weight. If you are overweight or have obesity, you might be able to lose weight with a lifestyle program that changes your behaviors and improves your eating and physical activity habits. Other alternatives include medications such as phentermine-topiramate and bupropion-naltrexone, which work differently but can still help with weight loss. Additionally, Ozempic may interact with other medications, including blood thinners, and may not be suitable for people taking certain medications. It is important to talk to a healthcare professional about the potential risks and benefits of using Ozempic for weight loss, and to carefully weigh the potential benefits against the potential risks. When it comes to weight loss medications, there are several options available that share similarities with Ozempic.
  • Wharton isn’t too concerned — he thinks clinicians can use techniques, such as increasing the dosage of the drugs slowly, to mitigate side effects.
  • “We’re putting you on a treatment that is treating the biological basis of the disease, and if you stop that medication, then you’re not going to have that effect, and you’re very likely to regain the weight back.”
  • There have been several anti-obesity medications that help suppress appetite and achieve weight loss.
  • From breakthrough results to difficult side effects, real patients share what it’s like to use GLP-1 medications
  • (Note, some iterations of semaglutide are currently in shortage).
  • GLP-1 drugs, like Wegovy and Ozempic, may not be good only for diabetes and weight-loss.
  • Wharton hopes both oral drugs will be available to consumers by 2026, though that depends how quickly they move through the FDA’s approval process.
That’s because the brain and the body actively don’t want to keep that weight off. The other side of the coin is, once you’ve lost weight but then gain some back, your body doesn’t want to defend the lower weight. Then, when you gain weight, your body’s energy balance shifts and your brain says, let’s defend this weight now. Our bodies have evolved to defend our body weight. Individuals with heart disease are on medications for the rest of their lives. This medication has garnered attention for its potential to deliver superior weight loss results compared to other GLP-1 agonists. Wegovy is essentially a higher-dose version of semaglutide, specifically approved for chronic weight management. Our approach merges cutting-edge telehealth innovations with effective weight loss solutions to make sustainable weight loss attainable. In this blog post, we will explore several medications similar to Ozempic, including their mechanisms of action, benefits, and potential side effects. Meanwhile, health care providers are pondering who should and shouldn’t use the medications and why. For commercially insured patients. The best way to save on GLP-1 and GIP/GLP-1 agonists is by using your health insurance. There are many ways to save on glucagon-like peptide-1 (GLP-1) receptor agonists like Ozempic (semaglutide) and Trulicity (dulaglutide). Linong Ji, a co-author and a diabetes researcher at Peking University People’s Hospital in Beijing, says ecnoglutide also improved risk factors for heart disease and diabetes, and reduced the amount of fat in people’s livers. People receiving ecnoglutide were also able to maintain their reduced weight after stopping treatment, regaining around 1% of their body weight over a 7-week period. At the maximum dose of 2.4 milligrams, 92.8% of people lost at least 5% of their body weight, compared with 14% of people receiving placebo injections. These drugs mimic the hormone GLP-1, which is involved in regulating appetite and managing blood-sugar levels. Ecnoglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist analogue, similar to the blockbuster obesity drug semaglutide. Pfizer, Amgen, OPKO Health, Germany’s Boehringer Ingelheim, China’s LeaderMed, Denmark’s Zealand Pharma and others are working on similar drugs, including pills. One-quarter of employers say obesity is the top factor for their health costs in a 2022 survey by the International Foundation of Employee Benefit Plans (IFEBP). “Ultimately, people can’t really look at Ozempic as a short-term fix to lose weight,” Sowa says. “These medications are expensive,” Shah says. Also, these medications aren’t designed to be used in the short-term.
  • In rare cases, some people may have an allergic reaction to the drug, or be at risk for a dangerous buildup of lactic acid in the bloodstream.
  • (I have a connective tissue disorder which makes this surgery extremely risky) I'm trying to save every penny to try and get the medication otherwise I'll have no choice but to do the surgery, which I really don't want, it's terrifying!
  • Using a GLP-1 drug stimulates insulin production so that blood sugar levels don’t fluctuate as much.
  • But within a few months, the same debilitating side effects returned.
  • Everything we know about these medicines suggests you can't stop them without gaining back the weight and losing any gained control over diabetes, Khan says.
  • The brain is good at keeping your weight static or letting you gain a few pounds.
  • It is FDA-approved for chronic weight management and works by reducing appetite.
  • Similar to nausea and vomiting, you’re more likely to experience diarrhea with higher semaglutide doses.
  • As an exercise science scholar, I have spent more than 15 years studying the effects of diet and exercise on the human body, primarily focused on body composition changes such as gaining skeletal muscle or losing body fat, or both.
Clinical efficacy of orlistat therapy in overweight and obese patients with Insulin-Treated Type 2 Diabetes. Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. These Ozempic alternatives for weight loss can be just as effective, depending on your needs. Childhood obesity requires early, aggressive treatment, new guidelines say To complicate matters, the American Academy of Pediatrics has suggested offering these drugs for teens and even tweens as young as age 12. At this time, we don’t know about the long-term harms or benefits because some of these drugs and dosing schedules are so new. Wegovy, the high-dose Ozempic used for weight loss, costs up to $1,350 a month, which, again, may have to be paid in perpetuity since any lost weight can pile back on if you stop taking it. Within 12 months, this resistance, combined with the decreased caloric needs from being lighter, matches the persistent effort to cut calories, and weight loss plateaus. New research points to the potential of GLP-1 agonists — the class of drugs that includes Ozempic — to treat obesity safely. Jefferies conducted the study in response to pharmaceutical companies developing weight loss pills and following a 2023 report it released studying the effects of weight loss on fuel costs. Airlines could have weight loss drug manufacturers to thank for savings if passengers become lighter, allowing carriers to spend less money on fuel. That’s why medical professionals prescribe Ozempic for weight loss, even though it isn’t FDA-approved for obesity. But as interest in semaglutide for weight loss continues to grow, health care professionals are finding ways to manage the demand. Currently, semaglutide is only approved for weight loss under the brand name Wegovy. Laxatives are used to treat constipation or clear the bowels before surgery; taking such medications for weight loss could lead to misuse and disordered eating. Medicare, which primarily provides health care for people aged 65 and older, was specifically prohibited by law in 2003 from covering weight-loss treatments. Osborn, like many fat rights and body neutrality activists and some health providers, rejects the idea of obesity as a disease. There's another drug for diabetes treatment with the same active ingredient, called Rybelsus, but it's taken orally. There are other treatments available for patients with diabetes, such as insulin, Buettner said. That high demand, similar to other drug shortages, has caused trouble for some diabetes patients when trying to get their prescribed Ozempic. High demand for Wegovy turned into more demand for Ozempic, as some people who couldn't get Wegovy turned to the lower-dosed sister drug meant for treating diabetes, prescribed off-label by their doctors. As Dr. Dan advises, "Be sure to talk to your care team and getting set up to make sure you figure out what is going to be the best option for you not only to continue managing your blood sugars, but also looking at managing your weight." If prescription or over-the-counter medication is not a choice or an option, certain foods—like flaxseed—are not only healthy but can help encourage fullness. While it may not continue your weight loss, it could help maintain the progress you've already made.
  • But Vilsbøll warns that the economics of weight loss therapies will not change overnight.
  • Indeed, if you drip the hormone GLP-1 into people’s veins, it reduces their appetite, leading to decreased food intake.
  • One of the most widely prescribed drugs of its kind, metformin is yet another medication approved by the FDA for the treatment of type-2 diabetes.
  • However, you’re likely to regain the lost weight once the medication is stopped.”
  • Diabetics in particular need to be careful of higher ketone levels in their blood and urine, which could be signs of a serious condition known as ketoacidosis.
  • Tirzepatide — Eli Lilly’s branded versions are sold as Mounjaro for blood sugar and Zepbound for weight loss — works on two hormones.
  • "The gold standard is excision of the excess skin, monsplasty, where the area above the pubic bone is incised, lifted and excess tissue removed, is one popular option," said Dr. Gallus, adding that these types of surgical procedures may also be performed in conjunction with other body contouring surgeries.
  • This helps better manage blood sugar in diabetes patients.
Some of the companies falsely claimed the drugs were FDA-approved. CBS News identified more than 100 companies advertising access to tirzepatide or semaglutide, both active ingredients in name-brand GLP-1 drugs that regulate insulin and suppress appetite. Readdy turned to online communities where thousands of people shared resources and where to find the drugs in short supply. Earlier this year, Josh opened up about taking weight loss medication for the first time.

Other Weight Loss Medications

An agonist is a substance that activates a receptor in the body, essentially turning on a biological signal. Scientists studied how GLP-1 works to make a more stable version that elicits the same beneficial effects, known as GLP-1 receptor agonists. Interestingly, your body naturally produces a little GLP-1, but it is degraded too quickly to be effective. Gina Leinninger, a Red Cedar Distinguished Professor of physiology in the College of Natural Science, specializes in obesity research. And it’s in rumors that circulate each time a celebrity appears with a new physique. There are ways patients can restore appearance and improve comfort after significant weight loss with GLP-1 medications. "Like any area of the body, significant weight loss from GLP-1 medications – or really any form of weight loss – can cause deflation of the soft tissues, resulting in a more baggy labia majora and possibly more protrusion of the labia minora," said Karen Horton, MD, MSc, FACS. It refers to the side effects of the rapid weight loss produced by any of the GLP-1 medications. “Ozempic face” is a term coined to describe the cosmetic effects of weight loss drugs. There are several GLP-1 medications now approved by the Food and Drug Administration for diabetes treatment.